Nexus News

Nexus Pharmaceuticals, Inc. Receives FDA Approval for EMERPHED® (ephedrine sulfate injection) Pre-Filled Syringe

Nexus Pharmaceuticals in Top 20 Best Workplaces in Chicago

Nexus Pharmaceuticals Inc. Receives FDA Approval of Erythromycin

Our Response to “Our Drug Supply Is Sick. How Can We Fix It?”

Nexus Pharmaceuticals Receives Patent for EMERPHED®

Nexus Pharmaceuticals Celebrates Grand Opening of New Facility

Industry Partnership on EMERPHED® (Ephedrine Sulfate)

Parkside Athletics Announces Partnership with Nexus

Nexus Pharmaceuticals Announces Launch of Succinylcholine Chloride Injection, USP

Nexus Pharmaceuticals Receives FDA Approval for Potassium Chloride in Water for Injection

Nexus Pharmaceuticals Announces Verbal to Occupy Authorization

Nexus Pharmaceuticals Discusses COVID-19 Response in BioForward Webinar

Nexus Pharmaceuticals sets month for $100M plant opening, preps drug for treating Covid patients

Nexus Pharmaceuticals Announces Diversity Certification

Nexus Pharmaceuticals Announces Great Place to Work® Certification

Nexus Pharmaceuticals Receives FDA Approval for Succinylcholine Chloride Injection, USP

Nexus Pharmaceuticals Named One of the 2020 Best Workplaces in Chicago by Great Place to Work®

Nexus Pharmaceuticals, Inc. Announces Approval of Emerphed™

Nexus Pharmaceuticals Official Response: Supply Chain Reassurance Amid COVID-19 Outbreak

Nexus Pharmaceuticals Ranks #574 in Inc. 5000 Fastest-Growing Private Companies in America

Nexus Pharmaceuticals to Build Industry-Leading Sterile Injectable Manufacturing Facility in Pleasant Prairie, Wisconsin

Nexus Pharmaceuticals Receives FDA Approval for Prochlorperazine Edisylate Injection, USP

Nexus Pharmaceuticals Announces FDA Approval of Dicyclomine HCl Injection, USP

Nexus Pharmaceuticals Announces FDA Approval of Busulfan Injection

Nexus Pharmaceuticals Receives FDA Approval for Arsenic Trioxide Injection in 10mg per 10mL Vial